Literature DB >> 811822

Meningococcal disease. Secondary attack rate and chemoprophylaxis in the United States, 1974.

.   

Abstract

Three hundred twenty-six reported cases of meningococcal disease in the United States from November 1973 through March 1974 were investigated. Three household members became ill with meningococcal disease following onset of the initial case in their household. The secondary attack rate was approximately 3/1,000 household members. In 60% of the households, members were given an antimicrobial drug as chemoprophylaxis for meningococcal disease, but only 35% received minocycline hydrochloride or rifampin, the two drugs now available for the eradication of sulfonamide-resistant meningococci from the nasopharynx. Only 26% given chemoprophylaxis received the drug within 24 hours after the patient's hospital admission. Survey results indicate that the secondary attack rate of meningococcal disease may justify the use of chemoprophylaxis, but that frequently in the United States, the drugs given are likely to be ineffective, give too late, or administered to persons who are not at high risk to meningococcal disease.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 811822

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  15 in total

Review 1.  Infections diseases: meningococcal disease.

Authors:  C A Hart
Journal:  West J Med       Date:  2000-08

Review 2.  Recognition, treatment and complications of meningococcal disease.

Authors:  F A Riordan; A P Thomson
Journal:  Paediatr Drugs       Date:  1999 Oct-Dec       Impact factor: 3.022

Review 3.  Prospects for vaccine prevention of meningococcal infection.

Authors:  Lee H Harrison
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

Review 4.  Effectiveness of vaccinating household contacts in addition to chemoprophylaxis after a case of meningococcal disease: a systematic review.

Authors:  M R Hoek; H Christensen; W Hellenbrand; P Stefanoff; M Howitz; J M Stuart
Journal:  Epidemiol Infect       Date:  2008-06-18       Impact factor: 2.451

5.  Which contacts of patients with meningococcal disease carry the pathogenic strain of Neisseria meningitidis? A population based study.

Authors:  B E Kristiansen; Y Tveten; A Jenkins
Journal:  BMJ       Date:  1998-09-05

Review 6.  Update on meningococcal disease with emphasis on pathogenesis and clinical management.

Authors:  M van Deuren; P Brandtzaeg; J W van der Meer
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

7.  Chemoprophylaxis for the prevention of bacterial meningitis.

Authors:  U B Schaad
Journal:  Infection       Date:  1984       Impact factor: 3.553

Review 8.  Effectiveness of antibiotics in preventing meningococcal disease after a case: systematic review.

Authors:  Bernadette Purcell; Susanne Samuelsson; Susan J M Hahné; Ingrid Ehrhard; Sigrid Heuberger; Ivonne Camaroni; André Charlett; James M Stuart
Journal:  BMJ       Date:  2004-06-05

9.  Clusters of meningococcal disease in France (1987-1988).

Authors:  R Olivares; B Hubert
Journal:  Eur J Epidemiol       Date:  1992-09       Impact factor: 8.082

10.  Carriers of Neisseria meningitidis in household contacts of meningococcal disease cases in Catalonia (Spain).

Authors:  N Cardeñosa; A Domínguez; A Orcau; H Pañella; P Godoy; S Minguell; N Camps; J A Vázquez
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.